Atmo Biosciences
Atmo Biosciences is a pioneering digital health company developing the world’s first ingestible gas-sensing capsule for monitoring gut health and microbiome function. Their mission is to transform the diagnosis and management of gastrointestinal disorders through innovative, non-invasive technology that provides real-time insights into gut physiology and microbiome activity. With a focus on clinical research, regulatory approval, and commercialisation, Atmo Biosciences aims to improve patient outcomes and advance understanding of gut health.
Industries
Nr. of Employees
small (1-50)
Atmo Biosciences
Patents
Products
Ingestible gas-sensing capsule system
An ingestible capsule platform that profiles gastrointestinal gases and multimodal onboard sensor signals during transit and transmits data wirelessly to a cloud platform for analysis and reporting.
Atmo Motility Bar
A food product offered as an optional standardized meal to support the Atmo Gas Capsule System, meeting FDA gluten-free labeling requirements.
Ingestible gas-sensing capsule system
An ingestible capsule platform that profiles gastrointestinal gases and multimodal onboard sensor signals during transit and transmits data wirelessly to a cloud platform for analysis and reporting.
Atmo Motility Bar
A food product offered as an optional standardized meal to support the Atmo Gas Capsule System, meeting FDA gluten-free labeling requirements.
Services
Provision of ingestible gas-sensing devices and operational collaboration with clinical investigators for deployment in human research, including support for multi-site comparative protocols and interventional microbiome studies.
Collection of streamed device data to a cloud platform for aggregation, visualization and generation of clinician and patient reports; foundational dataset support for downstream ML/AI analysis.
Provision of ingestible gas-sensing devices and operational collaboration with clinical investigators for deployment in human research, including support for multi-site comparative protocols and interventional microbiome studies.
Collection of streamed device data to a cloud platform for aggregation, visualization and generation of clinician and patient reports; foundational dataset support for downstream ML/AI analysis.
Expertise Areas
- Clinical trial management for medical devices
- Gastrointestinal motility measurement and diagnostics
- Digital biomarkers and cloud-based digital health platforms
- Medical device software lifecycle and regulatory submissions (e.g., IEC 62304, FDA submissions)
Key Technologies
- Ingestible gas sensors
- In vivo sensing of hydrogen, carbon dioxide and oxygen
- Onboard temperature and motion sensing in ingestible devices
- Wireless telemetry for medical sensors
News & Updates
Atmo Biosciences received FDA 510(k) clearance for their Gas Capsule System, enabling commercial use in the US.
Pivotal clinical study data validating the Gas Capsule for assessing gut transit times was published in a leading journal.
Partnerships with universities and research institutions to advance gut health diagnostics.
Atmo Biosciences' ingestible gas-sensing capsule offers a new way to assess gastrointestinal health non-invasively.
Granted US patent protecting the core technology of the ingestible gas-sensing capsule.
Atmo Biosciences received FDA 510(k) clearance for their Gas Capsule System, enabling commercial use in the US.
Pivotal clinical study data validating the Gas Capsule for assessing gut transit times was published in a leading journal.
Partnerships with universities and research institutions to advance gut health diagnostics.
Atmo Biosciences' ingestible gas-sensing capsule offers a new way to assess gastrointestinal health non-invasively.
Granted US patent protecting the core technology of the ingestible gas-sensing capsule.